Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance

Justin A. Budka(Indiana University Bloomington), Peter C. Hollenhorst(Indiana University Bloomington)
Genes & Cancer
November 11, 2018
Cited by 40


Related Papers